Antiseptic effect of a novel alcohol-free mouthwash: A convenient prophylactic alternative for high-risk patients

Oral Oncology

Volumn 43, Issue 2, 2007, Pages 159-164

  Bahna, Paul ^a   Hanna, Hend A ^a   Dvorak, Tanya ^a   Vaporciyan, Ara ^b   Chambers, Mark ^b   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antiseptic mouthwash; Biofilm; Brilliant green

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; GARDINE; LISTERINE; PERIOGARD; SCOPE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTISEPSIS; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH HYGIENE; MOUTH INFECTION; MOUTHWASH; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; DRUG EVALUATION, PRECLINICAL; ETHANOL; HUMANS; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOUTHWASHES; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS AERUGINOSA; QUATERNARY AMMONIUM COMPOUNDS; STAPHYLOCOCCUS AUREUS;

EID: 33846605063     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.02.002     Document Type: Article

References (42)

1. Abu-Elteen K.H., and Abu-Alteen R.M. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microb 21 1 (1998) 41-48
2. Budtz-Jorgensen E., Stenderup A., and Grabowski M. An epidemiological study of yeasts in elderly denture wearers. Community Dent Oral Epidemiol 3 (1975) 115-119
3. Webb B.C., Thomas C.J., Willcox M.D., Harty D.W., and Knox K.W. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J 43 (1998) 45-50
4. Belazi M., Velegraki A., Koussidou-Eremondi T., Andreadis D., Hini S., Arsenis G., et al. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microb Immunol 19 (2004) 347-351
5. Epstein J.B., Silverman Jr. S., Paggiarino D.A., Crockett S., Schubert M.M., Senzer N.N., et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 92 (2001) 875-885
6. Webb B.C., Thomas C.J., and Whittle T. A 2-year study of Candida-associated denture stomatitis treatment in aged care subjects. Gerodontology 22 3 (2005) 168-176
7. Epstein J.B., Hancock P.J., and Nantel S. Oral Candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 154-163
8. Odds F.C. Candida and candidiasis. A review and bibliography. 2nd ed. (1988), Bailliere Tindall, London p. 117
9. Stevens D.A., Greene S.I., and Lang O.S. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized double blind, placebo-controlled study of 100 mg oral fluconazole daily. Arch Intern Med 51 (1991) 2458-2464
10. Tapper-Jones L.M., Aldred M.J., Walker D.M., and Hayes T.M. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 34 (1981) 706-711
11. Bodey G., Bueltmann B., Duguid W., Gibbs D., Hanak H., Hotchi M., et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microb Infect Dis 11 2 (1992) 99-109
12. Lifson A.R., Hilton J.F., Westenhouse J.L., Canchola A.J., Samuel M.C., Katz M.H., et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 8 1 (1994) 73-79
13. Worthington H.V., and Clarkson J.E. Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy. Cochrane Syst Rev 66 8 (2002) 903-911
14. Woo S.B., Sonis S.T., Monopoli M.M., and Sonis A.L. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72 5 (1993) 1612-1617
15. Cayton R.M., Soutar C.A., Stanford C.F., Turner G.C., and Nunn A.J. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet August (1974) 303-307
16. Safdar N., Crnich C.J., and Maki D.G. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 50 6 (2005) 725-741
17. Okuda M., Kaneko Y., Ichinohe T., Ishihara K., and Okuda K. Reduction of potential respiratory pathogens by oral hygienic treatment in patients undergoing endotracheal anesthesia. J Anesth 17 2 (2003) 84-91
18. Shapiro S., Giertsen E., and Guggenheim B. An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouth rinses. Caries Res 36 2 (2002) 93-100
19. Green F.J. The sigma-Aldrich handbook of stains, dyes and indicators (1990), Aldrich Chemical, Co., Inc., Milwaukee, WI p 160
20. Remington J.P. Remington's pharmaceutical sciences. 13th ed. (1965), Easton, PA, Mack p 1257
21. Rogers T.H. Inhibition of sulfate-reducing bacteria in dyes. J Soc Chem Ind 59 (1940) 34-39
22. Tests and standards. New and unofficial remedies, American Medical Association. Lippincott: Philadelphia; 1953. p. 4.
23. Tentative final monograph for antiseptic drug products. Federal Register 59 27 (1994) Sec. 356.90
24. Kuhn D.M., George T., Chandra J., Mukherjee P.K., and Ghannoum M.A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46 (2002) 1773-1780
25. Ogata J., Minami K., Miyamoto H., et al. Gargling with povidone-iodine reduces the transport of bacteria during oral intubation. Can J Anaesth 51 9 (2004) 932-936
26. Houston S., Hougland P., Anderson J.J., LaRocco M., Kennedy V., and Gentry L.O. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 11 6 (2002) 567-570
27. Centers for Disease Control and Prevention Guidelines for Prevention of Nosocomial Pneumonia. MMWR 1997;46(RR-1):79.
28. Baxter A.D., Allan J., Bedard J., et al. Adherence to simple and effective measures reduces the incidence of ventilator-associated pneumonia. Can J Anaesth 52 5 (2005) 535-541
29. Jenkins S., Addy M., and Newcombe R.G. Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol 21 (1994) 250-255
30. Stanley A., Wilson M., and Newman H.N. The in vitro effects of chlorhexidine on subgingival plaque bacteria. J Clin Periodontol 16 (1989) 259-264
31. Brecx M., Brownstone E., Macdonald L., Gelskey S., and Cheang M. Efficacy of Listerine, Meridol and chlorhexidine mouthrinses as supplements to regular tooth cleaning measures. J Clin Periodontol 19 3 (1992) 202-207
32. Hancock P.J., Epstein J.B., and Sadler G.R. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc 69 (2003) 585-590
33. Foote R.L., Loprinzi C.L., Frank A.R., O'Fallon J.R., Gulavita S., Twefik H.H., et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 12 12 (1994) 2630-2633
34. Homann N., Jousimies-Somer H., Jokelainen K., Heine R., and Salaspuro M. High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis 18 9 (1997) 1739-1743
35. Sreenivasan P.K., Mattai J., Nabi N., Xu T., and Gaffar A. A simple approach to examine early oral microbial biofilm formation and the effects of treatments. Oral Microb Immunol 19 5 (2004) 297-302
36. Elmore J.G., and Horwitz R.I. Oral cancer and mouthwash use: evaluation of the epidemiologic evidence. Otolaryngol Head Neck Surg 113 3 (1995) 253-261
37. Winn D.M., Blot W.J., McLaughlin J.K., et al. Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 51 (1991) 3044-3047
38. Eldridge K.R., Finnie S.F., Stephens J.A., Mauad A.M., Munoz C.A., and Kettering J.D. Efficacy of an alcohol-free chlorhexidine mouthrinse as an antimicrobial agent. J Prosthet Dent 80 6 (1998) 685-690
39. Dantas S.R., and Moretti-Branchini M.L. Impact of antibiotic-resistant pathogens colonizing the respiratory secretions of patients in an extended-care area of the emergency department. Infect Control Hosp Epidemiol 24 5 (2003) 351-355
40. Martins S.T., Moreira M., Furtado G.H., et al. Application of control measures for infections caused by multi-resistant gram-negative bacteria in intensive care unit patient. Mem Inst Oswaldo Cruz 99 3 (2004) 331-334
41. Edmond M.B., and Wallace R.P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29 (1999) 239-244
42. Myoken Y., Sugat T., Fujita Y., Kohara T., and Mikami Y. Oropharyngeal Candida colonization and infection in neutropenic patients with hematologic malignancies. Oral Surg Oral Med Oral Med Oral Radiol Endod 97 2 (2004) 137-138